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Objective: The aim of this study was to compare the effect of dexmedetomidine with midazolam for intranasal premedication in 
children posted for elective surgery.
Trial design: This was a prospective, randomised, double-blinded clinical study.
Method: 60 children, 3 to 10 years of age, with American Society of Anaesthesiologists (ASA) physical status I, scheduled for elec-
tive surgery, were randomly divided into two groups, group D (dexmedetomidine) and group M (midazolam). Group D patients 
received intranasal dexmedetomidine 1 μg/kg and group M patients intranasal midazolam 0.2 mg/kg, approximately 30 minutes 
before induction of anaesthesia, in the form of a spray.
Outcome: Preoperative effects on heart rate, blood pressure, sedation and anxiety including parental separation and mask accept-
ance were assessed.
Results: Intranasal dexmedetomidine (1  μg/kg) premedication resulted in statistically significant but clinically unimportant 
lower heart rate and blood pressure at 10, 20, and 30 minutes following administration compared with intranasal midazolam 
(0.2 mg/kg). There were no episodes of hypotension or bradycardia. Children in group D achieved better parental separation and 
mask acceptance scores compared with group M.
Conclusion: Dexmedetomidine resulted in better parental separation and mask acceptance scores than intranasal midazolam. 
Thus it would seem to offer some advantage compared with midazolam.
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Introduction
Most paediatric patients have varying degrees of anxiety during the 
preoperative period, which may be due to separation from parents, 
or fear of injections or the operating theatre.1 This leads to stress, 
tachycardia, agitation or excessive crying, which make the 
management of such patients difficult during induction of 
anaesthesia. Preoperative anxiety is therefore an important concern 
for paediatric anaesthesiologists.2 Many anxiolytic medications 
have been tried with varying results. Of the benzodiazepines, 
midazolam has become the most frequently used premedication2,3 
due to its fast onset and short duration of action.
Intranasal midazolam as premedication in preschool children 
was first studied by Wilton and colleagues.4 The intranasal route 
has a slower onset of action compared with the intravenous 
route; however, it is not as painful as the intramuscular route, and 
it is absorbed directly into the systemic circulation, avoiding first-
pass metabolism.5,6 However, midazolam is also though rarely 
associated with side effects such as respiratory depression, cognitive 
impairment and excessive sedation.7
Recently α2-agonists have emerged as alternative anti-anxiety 
premedication in children. Dexmedetomidine is a centrally acting 
selective α2-agonist, which has an anxiolytic and sedative effect 
and is devoid of respiratory depression.8 It is odourless and does 
not cause mucosal stimulation, making it suitable for intranasal 
administration in paediatric patients.9,10
Objective
The aim of this study was to compare the effect of dexmedetomidine 
versus midazolam for intranasal premedication in children posted 
for elective surgery on preoperative anxiety, sedation, heart rate 
and systolic blood pressure as well as postoperative analgesic 
requirements.
Material and methods
This double-blind equally randomised (1:1) parallel group clinical 
study was carried out in Bhagat Phool Singh Govt Medical College 
and Hospital for Women after obtaining clearance from the ethical 
committee of the institute (No. BPSGMCW/RC78/IEC/15).
A total of 63 paediatric patients, 3 to 10  years of age, with 
American Society of Anaesthesiologists (ASA) physical status I, 
scheduled for elective surgery, were considered for this study. 
Children with ASA physical status 2 or more, runny nose or upper 
respiratory tract infection, any central nervous system disorder, 
refusal for intranasal administration or history of allergic reaction 
to dexmedetomidine or midazolam were excluded. In total 63 
children undergoing minor surgical procedures such as 
tonsillectomy, hernia repair, squint surgery or minor orthopaedic 
procedures were considered for this study. Of these, parents of 3 
patients declined to give consent for the study; a total of 60 
children were enrolled.
All patients were fasted overnight and clear fluids were allowed 
up to 4 hours prior to induction. In the morning, on the day of 
surgery, children were taken into the preoperative room with 
one parent allowed to accompany them. After informing the 
parent about the benefits of intranasal anti-anxiety premedication 
written consent was obtained from those willing to participate in 
the study. The children were randomly divided into two groups, 
group D and group M, using a computer-generated sequence. 
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Group D patients received intranasal dexmedetomidine (1 μg/kg) 
and group M patients were given intranasal midazolam (0.2 mg/
kg) approximately 30 minutes before induction of anaesthesia, in 
the form of a spray. Both the drugs used were free of any kind of 
preservative. Children were made to lie on one side (lateral position) 
and the calculated dose of drug diluted to a total volume of 1 ml 
was administered, 0.5 ml in each nostril, with the help of a spray 
device fitted on the top of a syringe (Figure 1). The investigator 
(anaesthesiologist) involved in preparing and administering the 
drug was different from the one (anaesthesiologist) responsible 
for further assessment and management of the patient.
Vital signs (heart rate, blood pressure, oxygen saturation) were 
recorded before administering the intranasal drug and again at an 
interval of every 10 minutes, for 30 minutes. The Modified Observers 
Assessment of Alertness/Sedation Scale (MOAA/S) (Table 1)11 was 
used to assess sedation. Also the response to parent separation was 
assessed at 30 minutes and was graded on a four-point 
Parental Separation Anxiety Scale (PSAS) (Table 2).12–14 Thirty 
minutes after premedication children were taken into the operating 
room and acceptance of a mask was assessed using the Mask 
Acceptance Scale (MAS) (Table 3).12–15 Children were transported to 
the operating room where mask induction was carried out with 
4–5% sevoflurane in oxygen via a Jackson Rees circuit.
Statistical analysis
Data were analysed using SPSS® version 16 (Statistical Packages 
for the Social Sciences, Chicago, IL, USA). Results were expressed as 
mean  ±  standard deviation (SD) or numbers (percentages). 
Quantitative data were compared using one-way analysis of 
variance (ANOVA) and unpaired t-test; qualitative data were 
analysed using a chi-square test. A p-value of < 0.05 was considered 
statistically significant.
Results
A total of 60 children were randomly divided into two groups with 
30 patients each. Demographic characteristics of both groups, i.e. 
age, sex and weight, were comparable. Children underwent minor 
surgical procedures such as tonsillectomy, hernia repair, squint 
surgery or minor orthopaedic procedures like K-wiring etc. The 
duration of anaesthesia and surgery was similar in both groups 
(Table 4). No local or regional anaesthesia was administered to these 
children apart from general anaesthesia.
There were no significant differences between groups in baseline 
preoperative heart rate, blood pressure and oxygen saturation prior 
to premedication. After premedication, heart rate and systolic blood 
pressure were significantly lower in children who received 
dexmedetomidine, at 10, 20 and 30 minutes (Table 5); there was no 
significant difference in oxygen saturation between groups. The 
MOAA/S scores were comparable in both groups before 
premedication. However, group D had a significantly lower MOAA/S 
(Table 5) score at the time of transfer to the operating theatre 
(p-value 0.003). A greater number of children in group D achieved a 
parental separation and mask acceptance of 1 or 2 when compared 
with group M but this was not statistically significant (Table 6). Both 
parental separation score (p-value 0.0234) and mask acceptance 
score (p-value 0.0472) was significantly lower in group D (Figure 2, 
Table 7). None of the children in either group had any undesirable 
effects like hypotension, bradycardia, vomiting, excessive sedation, 
nasal irritation etc.
Discussion
Midazolam is the most commonly used anxiolytic premedication 
in young children. It facilitates gamma amino butyric acid (GABA) 
receptor-mediated chloride conductance, which has an inhibitory 
effect on neurons in the cerebral cortex. It has been successfully 
used through various routes, e.g. intravenous, intramuscular, oral 
Figure 1: Syringe assembly used for the intranasal spray.
Figure 2: Parental separation anxiety scale and mask acceptance scale 
in groups D and M.
Table 1: Modified observer’s assessment of alertness/sedation scale
Scale item Score
Agitated 6
Responds readily to name spoken in normal tone 
(alert)
5
Lethargic response to name spoken in normal 
tone
4
Responds only after name is called loudly and/or 
repeatedly
3
Responds only after mild prodding or shaking 2
Does not respond to mild prodding or shaking 1
Does not respond to deep stimulus 0
Table 2: Parental separation anxiety scale
Behaviour of the child 
during separation from 
parents
Criteria Score
Excellent Patient unafraid, cooperative, 
or asleep
1
Good Slightly afraid/crying, quiet 
with reassurance
2
Fair Moderately afraid and crying, 
not quiet with reassurance
3
Poor Crying, need for restraint 4
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and intranasal.2 A study by Malinovsky et al.16 also showed that 
intranasal midazolam 0.2  mg/kg has a faster onset of sedation 
compared with other routes. Recently, α2-receptor agonists such 
as dexmedetomidine have also been found to be useful for 
premedication in children. These drugs act on central α2 receptors 
located at the presynaptic terminal where they mainly cause 
inhibition of release of noradrenaline.17 The site of action of 
dexmedetomidine is in locus coeruleus where it causes EEG activity 
similar to normal sleep. This results in anxiolytic effects, sedation 
and analgesia without excessive drowsiness.18 The intranasal route 
was used in our study as it is non-invasive, unlike intravenous and 
intramuscular routes, and produces a more rapid onset of action 
than the oral route.
Our study confirms other reports comparing dexmedetomidine 
with midazolam premedication that found a stable heart rate 
and blood pressure, and better parent separation and mask 
acceptance, with comparable sedative effects. Previous 
studies10,19,20 have found dexmedetomidine to be highly effective 
compared with midazolam. Mustafa et al.19 compared intranasal 
dexmedetomidine with intranasal midazolam and ketamine and 
found that dexmedetomidine achieved faster sedation and 
better child–parent separation scores. In a study by Yuen et al. 
intranasal dexmedetomidine was found to produce more 
sedation than oral midazolam.21
The dose of intranasal dexmedetomidine of 1 µg/kilogram has 
been shown to have a time of sedation onset of approximately 
25 minutes and median duration of approximately 85 minutes.21 
However, Telon et al. reported that with a dose of 2 µg/kg onset 
time of intranasal dexmedetomidine was 15 minutes when 
administered with a metered dose atomizer.22 Also it has been 
shown that bio-availability of an intranasal drug is greater when 
used in the form of a spray.23 In our study both midazolam and 
dexmedetomidine were administered in the form of a spray and 
children were observed for 30 minutes before induction. 
Therefore the MOAA/S was significantly less at 30 minutes after 
intranasal dexmedetomidine. This also resulted in easier child–
parent separation and better mask acceptance.
Table 3: Response to induction (mask acceptance scale)
1 Combative, crying
2 Moderate fear of mask, not easily calmed
3 Cooperative with reassurance
4 Calm, cooperative
Table 4: Demographic data of patients
Item
Midazolam group (n = 30) Dexmedetomidine group (n = 30)
Age (years) 5.91 ± 0.46 5.86 ± 0.40
Sex (M:F) 14:16 17:13
Weight (kg) 18.25 ± 4.28 17.92 ± 4.18
Duration of anaesthesia (min) 34.54 ± 4.01 33.89 ±3 .28
Duration of procedure (minutes) 26.43 ± 3.96 25.71 ± 4.09
Table 5: Comparison of preoperative vitals and modified observer’s assessment of alertness/sedation scale in midazolam group and dexmedetomidine 
group
Factor Time interval 
(minutes)
Midazolam group  
(n = 30)
Dexmedetomidine 
group (n = 30)
p-value
Heart rate Before premedication 0 112.76 ± 7.14 113.07 ± 6.78 0.434
After premedication 10 108.43 ± 6.71 101.43 ± 9.77 0.002
20 106.03 ± 5.11 99.2 ± 6.905 0.001
30 99.93 ± 5.71 94.23 ± 9.33 0.006
Systolic blood pressure Before premedication 0 107.43 ± 6.15 107.5 ± 7.06 0.969
After premedication 10 107.63 ± 6.020 104.17 ± 5.712 0.0258
20 107.8 ± 6.69 103.7 ± 7.32 0.0273
30 106.67 ± 6.92 102.83 ± 6.54 0.0315
Oxygen saturation Before premedication 0 98.5 ± 1.106 98.23 ± 1.07 0.347
After premedication 10 98.3 ± 1.022 98.77 ± 1.10 0.095
20 98.6 ± 1.1.163 98.83 ± 1.085 0.425




Before premedication 0 4.8 ± 0.99 4.86 ± 1.008 0.797
After premedication 10 3.43 ± 0.89 3.33 ± 1.03 0.689
20 3.53 ± 1.14 2.93 ± 1.143 0.352
30 3.23 ± 0.82 2.4 ± 0.855 0.003
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12.  Isik B, Arslan B, Tunga AD, et al. Dexmedetomidine decreases 
emergence agitation in pediatric patients after sevoflurane 
anesthesia without surgery. Pediatr Anesth. 2006;16:748–53.
13.  Weldon BC, Watcha MF, White PF. Oral midazolam in children: effect 
of time and adjunctive therapy. Anesth Analg. 1992;75:51–5.
14.  Mountain BW, Smithson L, Cramolini M, et al. Dexmedetomidine as 
a pediatric anesthetic premedication to reduce anxiety and to deter 
emergence delirium. AANA J. 2011;79:219–24.
15.  Shukry M, Clyde MC, Kalarickal PL, et al. Does dexmedetomidine 
prevent emergence delirium in children after sevoflurane based 
general anesthesia? Paediatr Anaesth. 2005;15:1098–104.
16.  Malinovsky JM, Lejus C, Populaire C, et al. Premedication with 
midazolam in children. Effect of intranasal, rectal and oral routes on 
plasma concentration. Anaethesia. 1995;50:351–4.
17.  Levick JR. Control of blood vessels II: extrinsic control. In: Levick JR, 
editor. An introduction to cardiovascular physiology. 3rd ed. London: 
Hodder Arnold; 2000. Chapter 14.1, Sympathetic vasoconstrictor 
nerves.
18.  Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor 
agonists. Their pharmacology and therapeutic role. Anaesthesia. 
1999;54:146–65.
19.  Mostafa MG, Morsy KM. Premedication with intranasal 
dexmedetomidine, midazolam and ketamine for children undergoing 
bone marrow biopsy and aspirate. Egypt J Anaesth. 2013;29:131–5.
20.  Yuen VM, Hui TW, Irwin MG, et al. A comparisonof intranasal 
dexmedetomidine and oral midazolam for premedication in pediatric 
anesthesia: a double-blinded randomized controlled trial. Anesth 
Analg. 2008;106:1715–21.
21.  Yuen VM, Hui TW, Irwin MG, et al. Optimal timing for the 
administration of intranasal dexmedetomidine for premedication in 
children. Anesthesia. 2010;65:922–9.
22.  Talon MD, Woodson LC, Sherwood ER, et al. Intranasal 
dexmedetomidine premedication is comparable with midazolam in 
burn children undergoing reconstructive surgery. J Burn Care Res. 
2009;30:599–605.
23.  Wolfe TR, Bernstone T. Intranasal drug delivery: an alternative to 
intravenous administration in selected emergency cases. J Emerg 
Nurs. 2004;30:141–7.
Our study showed that dexmedetomidine reduces both pulse 
rate and systolic blood pressure in the preoperative period, 
though clinically significant hypotension or bradycardia was not 
observed in children in group D. Children who received intranasal 
dexmedetomidine premedication had lower anxiety levels, and 
better mask acceptance and parental separation compared with 
intranasal midazolam. However, the statistical significance of the 
analgesic-sparing effect could not be determined due to the 
small sample size. Our study was designed to compare the efficacy 
of two drugs for premedication in children. So a sample size just 
adequate for this purpose was calculated and studied. Therefore, 
further studies with higher sample size are required to establish 
the usefulness of intranasal dexmedetomidine as perioperative 
anxiolytic in children.
Conclusion
In conclusion, premedication with intranasal dexmedetomidine 
1 μg/kg resulted in lower anxiety levels, and better parent separation 
and mask acceptance as compared with intranasal midazolam 
0.2 mg/kg and would seem to offer some advantage.
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Table 6: Comparison of parental separation anxiety scale and mask acceptance scale in midazolam group and dexmedetomidine group
Factor Midazolam group (n = 30) Dexmedetomidine group (n = 30)
Parental Separation Anxiety Scale No separation problems (score = 1 or 2) 17 24
Separation problems (score = 3 or 4) 13 06
Mask Acceptance Scale Good acceptance (score = 1 or 2) 16 23
Poor acceptance (score = 3 or 4) 14 07
Table 7: Parental separation anxiety score and mask acceptance score in midazolam group and dexmedetomidine group at the time of transfer to the 
operating theatre
Mean ± SD Midazolam group (n = 30) Dexmedetomidine group (n = 30) p-value
Parental Separation Anxiety Scale (PSAS) 2.333 ± 0.9942 1.800 ± 0.7611 0.0234
Mask Acceptance Scale (MAS) 2.333 ± 1.028 1.833 ± 0.8743 0.0472
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